Amir Reza Vosoughi

Amir Reza Vosoughi

Auto-generated profile, based on publicly available information

Amir Reza Vosoughi

Orthopedic & Rehabilitation Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2019 in The FEBS Journal
Verified
Journal Article
Open access
PDF file
SGSaeid Ghavami
Saeid Ghavami
NKNavid Koleini
Navid Koleini
ESEhsan Samiei
Ehsan Samiei
MAMahmoud Aghaei
Mahmoud Aghaei
LCLaura K. Cole
Laura K. Cole
Saeid GhavamiSaeid Ghavami
Saeid Ghavami
Temozolomide (TMZ) is a chemotherapy agent used to treat Grade IV astrocytoma, also known as glioblastoma (GBM). TMZ treatment causes DNA damage that results in tumor cell apoptosis and increases the survival rate of GBM patients. However, chemoresistance as a result of TMZ‐induced autophagy significantly reduces this anticancer effects over time. Statins are competitive inhibitors of HMG‐CoA reductase, the rate‐limiting enzyme of the mevalonate (MEV) cascade. Statins are best known for their cholesterol (CH)‐lowering effect. Long‐term consumption of statins, prior to and in parallel with other cancer therapeutic approaches, has been reported to increase the survival rate of patients with various forms of cancers. In this study, we investigated the potentiation of TMZ‐induced apoptosis by simvastatin (Simva) in human GBM cell lines and patient GBM cells, using cell monolayers and three‐dimensional cell culture systems. The incubation of cells with a combination of Simva and TMZ resulted in a significant increase in apoptotic cells compared to cells treated with TMZ alone. Incubation of cells with CH or MEV cascade intermediates failed to compensate the decrease in cell viability induced by the combined Simva and TMZ treatment. Simva treatment inhibited the autophagy flux induced by TMZ by blocking autophago‐lysosome formation. Our results suggest that Simva sensitizes GBM cells to TMZ‐induced cell death in a MEV cascade‐independent manner and identifies the inhibition of autophagosome‐lysosome fusion as a promising therapeutic strategy in the treatment of GBM.

1 January 2007 in Lipids in Health and Disease
Verified
Journal Article
Open access
PDF file
JKJavad Kojuri
Javad Kojuri
AVAmir R Vosoughi
Amir R Vosoughi
MAMajid Akrami
Majid Akrami
Hyperlipidemia as a major risk factor of atherosclerosis is treated with different drugs. Concerning length of therapy and vast majority of side effects, herbal medication may be suitable substitute for these drugs. In this single-blind, placebo controlled study, lipid profiles of 150 hyperlipidemic patients in cardiology outpatient department of Shiraz University of Medical Sciences were checked at same conditions. They were divided into three equal groups randomly (each composing of 50 patients). They were given enteric-coated garlic powder tablet (equal to 400 mg garlic, 1 mg allicin) twice daily, anethum tablet (650 mg) twice daily, and placebo tablet. All patients were put on NCEP type Π diet and Six weeks later, lipid profiles were checked. In garlic group: total cholesterol (decreased by 26.82 mg/dl, 12.1% reduction, and P-value: .000), and LDL-cholesterol (decreased by 22.18 mg/dl, 17.3% reduction, and P-value: .000) dropped. HDL-cholesterol (increased by 10.02 mg/dl, 15.7% increase, and P-value: .000) increased. Although triglyceride dropped by 13.72 mg/dl (6.3%) but this was not significant statistically (P-value: .222). In anethum group: surprisingly, triglyceride increased by 14.74 mg/dl (6.0%). Anethum could reduce total cholesterol by 0.4 % and LDL-cholesterol by 6.3% but these were not significant statistically (P-value: .828, and .210, respectively). Anethum has no significant effect on lipid profile, but garlic tablet has significant favorable effect on cholesterol, LDL-cholesterol, and HDL-cholesterol. Garlic may play an important role in therapy of hypercholesterolemia.


16 July 2020 in Foot & Ankle International
Verified
Journal Article
Closed access
PDF file
GHGavin John Heyes
Gavin John Heyes
AVAmir R. Vosoughi
Amir R. Vosoughi
LWLizzy Weigelt
Lizzy Weigelt
LMLyndon Mason
Lyndon Mason
AMAndrew Molloy
Andrew Molloy
Hallux valgus recurrence is an unsatisfactory complication, with many causes postulated. This study investigated the effect of pes planus on recurrence after scarf osteotomy. A total of 183 feet were retrospectively reviewed. All patients were treated with a scarf osteotomy and if required Akin osteotomy. We measured preoperative lateral talus first metatarsal angle (T1MA) to study pes planus; an angle of under −4 degrees was considered pes planus. We measured pre and postoperative hallux valgus angle (HVA), intermetatarsal angle (IMA), and sesamoid location. In total 164 feet were suitable for inclusion, with follow-up of at least 6 months (10 males and 154 females, mean age: 52 years). Recurrence frequency (HVA greater than 15 degrees) was 27 feet (16%). Hallux valgus recurrence was not influenced by gender (P value = .66) or preoperative IMA (P value = .48). Preoperative HVA greater than 35 degrees was associated with increased frequency of recurrence (P value = .004). Those with T1MA less than −10 degrees demonstrated progression in HVA and deterioration in sesamoid location up to 6 months postoperatively (P value = .038). HVA did not progress beyond 6 months. The prevalence of recurrent hallux valgus with normal T1MA was 1%, in T1MA −4 to −10 degrees it was 29% and in T1MA less than −10 degrees it was 47% (P value <.001). Breaks in T1MA less than −4 degrees were found at the naviculocuneiform joint in 68% of feet in this series. The prevalence of hallux valgus recurrence correlated with the severity of pes planus. Level III, retrospective cohort study.

20 October 2016 in MUSCULOSKELETAL SURGERY
Verified
Journal Article
Closed access
PDF file
AVA. R. Vosoughi
A. R. Vosoughi
MEM. J. Emami
M. J. Emami
BPB. Pourabbas
B. Pourabbas
HMH. Mahdaviazad
H. Mahdaviazad

1 January 2022 in Foot and Ankle Surgery
Verified
Journal Article
Closed access
AVAmir Reza Vosoughi
Amir Reza Vosoughi
RBRoham Borazjani
Roham Borazjani
NGNiayesh Ghasemi
Niayesh Ghasemi
SFShiva Fathi
Shiva Fathi
AMAmirali Mashhadiagha
Amirali Mashhadiagha
AHAmir Human Hoveidaei
Amir Human Hoveidaei